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TRAMM was originally identified as a protein that co-precipitates with the TRAPP 
(transport protein particle) complex that functions in membrane trafficking. Recent work 
in our laboratory suggested a role for this protein in mitosis, specifically in chromosome 
congression prior to metaphase. In the early stages of mitosis, TRAMM is post-
translationally modified by phosphorylation. Knockdown of the protein causes it to affect 
the localization of various kinetochore proteins with the strongest effect on CENP-E. The 
two proteins were also shown to interact using a yeast two hybrid assay (Milev et al., 
2015). 
 
In this study, I show that TRAMM also interacts with CENP-E through a co-
immunoprecipitaiton assay and this interaction appears to be enhanced in mitotic 
lysates. Using various inhibitors of mitotic kinases, I further show that only inhibition of 
Cdk1 prevents the phosphorylation of TRAMM. This suggests that Cdk1, apart from the 
other mitotic kinases, has a role in phosphorylating TRAMM. Furthermore, I also use 
bioinformatics tools to predict the structure of TRAMM. Finally I express and purify a 
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Chapter 1: Introduction 
 
1.1 Membrane trafficking 
 
Membrane trafficking is an essential cellular process that occurs in virtually every cell. 
This process allows the cell to specifically deliver cargo molecules between its 
organelles, as well as their secretion to the extracellular space through exocytosis. This 
process is mediated by transport vesicles. The appropriate targeting of a vesicle requires 
a series of molecular events including sorting, budding, movement, tethering, and fusion 
of the vesicle. Each step increases the specificity of the trafficking process (Bonifacino 
and Glick, 2004). An example of this would be Endoplasmic Reticulum (ER) to Golgi 
traffic, where proteins are properly folded and packaged into coated vesicles (COPII), 
and transported from the ER to the Golgi (Hughes and Stephens 2008). In the Golgi, 
proteins are subjected to post translational modifications such as glycosylation, 
phosphorylation and packaging into carrier vesicles that bud from the trans-Golgi, 
allowing them to be transported to other cellular locations (Godi et al., 2004). 
1.1.1 TRAPP complex 
 
In 1998, Sacher and colleagues described the transport protein particle (TRAPP) 
complex while working on a protein called Bet3 (a 22KDa hydrophilic protein involved in 
ER-Golgi transport) (Sacher et al., 1998).Through epitope tagging of Bet3p and its 
purification from cell lysates in Saccharomyces cerevisiae, Bet3p was found to be a 
member of a large complex that is now known as TRAPP. This complex is specifically 
involved in the tethering process, as it is the first contact between vesicles and their 
target membrane. The TRAPP complex is considered to be one of the best studied of 
the multisubunit tethering complexes at the molecular level (Sacher et al., 2008). 
 
TRAPP I, II and III are three forms of TRAPP that were found to co-exist in S. cerevisiae. 
Studies show that all TRAPP complexes share the function of being a guanine 
nucleotide exchange factor (GEF) for Ypt1. This is accomplished by conserving 4 of their 
typical 6 core subunits: Bet3p, Bet5p, Trs23p, and Trs31p (Kim et al., 2006). These 
conserved subunits along with two additional subunits (Trs33p and Trs20p) form the 





binding to COPII-coated ER-derived vesicles, and brings them to closer proximity of the 
acceptor membranes (Sacher et al., 1998). TRAPP II is composed of 10 subunits (the 
TRAPP I subunits and an additional 4 subunits; Trs65p, Trs120p, Trs130p and Tca17p) 
found to function at the level of intra-Golgi and late Golgi trafficking (Sacher et al., 2001). 
TRAPP III is made up of 7 subunits (the six TRAPP I subunits and an additional subunit 
called Trs85p) and functions in selective and non-selective autophagy (Lynch-Day et al., 
2010). 
 
The TRAPP complex is conserved throughout eukaryotes. It is found in mammals in an 
organized fashion represented by TRAPP II (consisting of C1, C2, C2L, C3, C4, C5, C6, 
C9, and C10) and TRAPP III (C1, C2, C2L, C3, C4, C5, C6, C8, C11, C12, C13) (Zong 
et al., 2011). This includes mammalian orthologues and additional unique mammalian 
subunits such as TRAMM (previously called TRAPPC12) and TRAPPC13 (also known 
as FLJ13611) (Table 1.1) (Sacher and Milev, 2016).TRAPP II and TRAPP III share the 
basic core subunits. What differentiates them are the C9 and C10 subunits in TRAPP II 
while TRAPP III contains C8, C11, C12, and C13 (Bassik et al., 2013). The TRAPP 
complex function is partially conserved since the mammalian TRAPP II complex is a 
GEF for Rab1 (Rab1 is an orthologue to yeast Ypt1p) (Ishikawa et al., 2009). The 
mammalian TRAPP III complex is functionally similar to that of yeast as it is involved in 




Trafficking of membranes and mitosis (TRAMM) is a 79 KDa protein that is one of the 
subunits of the mammalian TRAPP III complex (Scrivens et al., 2011). Depletion of 
TRAMM in HeLa cells results in Golgi fragmentation suggesting that it functions at an 
early stage of ER-to-Golgi trafficking (Scrivens et al. 2011). Interestingly, a recent 
discovery in our laboratory has shown that TRAMM has an important function in mitosis. 
TRAMM is the only subunit of TRAPP complex that has a role in mitosis (Figure 1.1(A)). 
Upon depletion of TRAMM, some chromosomes failed to congress to the metaphase 
plate and the cells remained arrested in this pre-metaphasestate of mitosis (Figure 
1.1(C)). TRAMM is phosphorylated during early mitosis (Figure 1.1(B)) and this 
phosphorylation plays a critical role in CENP-E recruitment to the kinetochores (see 








Figure 1.1 TRAMM has a role in mitosis. (A) Hela cells were photographed by bright 
field microscopy 24h after treatment with siRNA against the TRAPP subunits indicated. 
Cells were quantified by counting the number of mitotic cells in multiple fields. Depletion 
of TRAMM arrested cells in mitosis. Quantification of this effect indicated that the mitotic 
index increased from 6.4% for untreated (NC) or nonspecific siRNA (siNS) to 29.7% 
after depletion of TRAMM. This effect was not seen for other subunits of TRAPP 
complex indicating that TRAMM is the only subunit of TRAPP that has a role in mitosis. 
(B) Western blots of Hela cell lysates probed for anti-TRAMM, anti-phospho histone-H3 
(p-Hist-H3) (mitotic marker) and anti-tubulin (loading control). Hela cells were 
leftuntreated (asynchronous), treated with thymidine to arrest the cells at G1/S (Thym), 
or treated with colcemid (colc) to arrest the cells in mitosis. Colcemid treatment of cells 
reduced the mobility of TRAMM from 79 KDa (in asynchronous cells and thymidine-
treated cells) to 83 KDa. Phosphatase treatment increased the mobility of colcemid-





phosphorylated. (C) Hela cells expressing fluorescently labeled histone H2B were 
treated with non-specific (NS top row) or TRAMM (bottom row) siRNA. The cells were 
subjected to live cell imaging 20 hours after treatment. Time at 0min refers to nuclear 
envelope break down in prophase (NEBD). TRAMM knockdown (KD) led to the 
presence of polar chromosomes that never migrated to the metaphase plate indicating 
that TRAMM has a role in chromosome congression (Milev et al., 2015). 
 
 
1.1.3 Membrane trafficking proteins in mitosis 
 
Proteins with at least two unrelated functions are described by the term “moonlighting.” 
Studies have shown that many membrane trafficking proteins have “moonlighting” 
functions in mitosis. TRAMM is one amongst the many such as clathrin, dynamin, epsin, 
and cyclin-G associated kinases (GAKs) (Royle, 2012). 
 
Clathrin is a protein coat used by cells to assist in the budding of vesicles from their 
respective donor membranes (Maro et al., 1985). Clathrin is also found in mitotic 
spindles, and its depletion destabilizes kinetochore fibers even though they are entirely 
lacking membranes (Royle et al., 2005). GAK is an  auxillin homologue that is a 
threonine and serine kinase that is associated with cyclin-G and functions in the removal 
of clathrin from clathrin coated vesicles. Interestingly, the depletion of GAK resulted in 
cellular arrest in pre-metaphase, showing mitotic moonlighting functionality (Greener et 




Mitosis starts with chromosome condensation and ends with two daughter cells that 
have identical numbers of chromosomes. This process comprises 5 phases: prophase, 
prometaphase, metaphase, anaphase, and telophase (De Souza and Osmani, 2007).  
 
During prophase, the chromosomes begin to condense and are held together in pairs by 
the action of cohesion complexes. This is followed by nuclear breakdown (in most 
eukaryotes) and centrosomes begin to move towards opposite poles of the cell (Howell 





kinetochores at the centromeres of the condensed chromosomes and spindle 
microtubules start to appear from centrosomes in preparation for prometaphase (see 
below) (Muller-Reichert et al., 2007). Microtubule elongation and attachment to the 
kinetochores, and further chromosomal condensation for the purpose of alignment at the 
metaphase plate occur during prometaphase (May and Hardwick, 2006). The movement 
of chromosomes to the metaphase plate at the center of the cell is known as 
chromosome congression and upon completion of this process the cells are said to be in 
metaphase (May and Hardwick, 2006). Anaphase corresponds to the movement of the 
sister chromatids to opposite poles of the cell via microtubule depolymerization. The last 
phase of mitosis is telophase, where the nuclear membrane reforms, nuclei reappear, 
chromosomes decondense to chromatin, and the remaining spindle microtubules 
depolymerize (Bucciarelli et al., 2003). Concurrently with telophase, cytokinesis forms 
actin-myosin rings in the center of the cell, which results in cellular abscission to create 




Kinetochores (KT) are inner proteinaceous complexes (greater than 200 proteins in 
mammalian cells) that assemble on the centromere of each chromosome (Errico et al., 
2010). KTs mediate the interactions between the centromere of sister chromatids and 
spindle microtubules (MTs), mediating all movements of chromosomes during mitosis 
(O’Connor et al., 2008). They have been conserved throughout eukaryotes due to their 
evolutionary importance in mitosis and are composed of two main core components: the 
Constitutive Centromere-Associated Network (CCAN) and Knl1-Mis12 -Ndc80 (KMN) 
complex network (Godek et al., 2015). 
 
CCAN are part of the inner portion of KTs that directly bind to the centromeric 
nucleosomes and links them to the KMN network. This is possible due to CCAN’s 
histone H3 variant known as CENP-A, which is a component of a larger 16 centromeric 
protein complex (Figure 1.1) (Musacchio and Salmon, 2007). 
 
The KMN network is located on the outer portion and is responsible for the interaction 
with kinetochore microtubules (the binding of KTs to MTs) and serves as a spindle 





assembles post-NEBD and consists of approximately 20 proteins (mostly microtubule 
interacting proteins) adjacent to the CCAN. These outer KT proteins include KMN, 
mitotic checkpoint proteins, and motor proteins including CENP-E (see below) 
(Musacchio and Salmon, 2007). The KMN network, consisting of 3 major components 
(Knl1, Mis12 and Ndc80 complex) associates with KTs.  
 
 
Figure 1.2 Kinetochore Structure at the Centromere. This cross-sectional view of the  
kinetochores show its complex macro structure consisting of many protein complexes. 
These complexes include the CENP-A protein complex (consisting of 16 centromere 
proteins), KMN network, SAC, CPC, APC, INCENP, etc. Microtubule attachment is 
present at the KMN network. This structure represents post nuclear envelope breakdown 
(NEBD) due to CENP-E binding to MT. SAC seems to be inactive in this representation 
due to the soluble Cdc20 available to activate APC. Although Mad1:Mad2 complex is 
present, there are no interactions with open Mad2 and no presence of Mad2:Cdc20 





(Musacchio and Salmon, 2007) 
 
 
The outer kinetochore assembly and recruitment is performed by the Mis12 complex, as 
it recruits Knl1 that further draws the centromere and spindle assembly checkpoint 
(SAC) proteins into proximity (Cheeseman et al., 2008). The Ndc80 complex increases 
the binding affinity of KT to the MT via electrostatic interactions with the aid of Mis12 and 
Knl1 (Cheeseman et al., 2008). The Ndc80 complex also interacts with the spindle- and 
kinetochore-associated (Ska) complex, which is required for anaphase transition and 
onset (Errico et al., 2010). Unstable attachments of sister chromatids to the spindle 
microtubules can activate signaling of spindle checkpoints causing mitotic arrest 
(Sivakumar et al., 2016). The binding affinity of the KT to the MT can be regulated by 
phosphorylating the proteins in the KMN network by Aurora B kinase (see below). These 
mechanisms reduce the possibility of chromosome segregation defects (Cheeseman et 
al., 2008).  
 
1.4 Mitotic Kinases 
 
Protein phosphorylation is a common process for cellular regulation and cell signaling. 
Cellular regulation allows for check point control during complex cellular processes such 
as switching through all the different phases of the cell cycle. Some of the most critical 
kinases that control the progression of mitosis in the cell cycle are cyclin-dependent 
kinases (CDKs), Polo-like kinases (Plks), and Aurora Kinases (Santamaría et al., 2007). 
 
1.4.1 Cyclin-dependent Kinases 
 
Mammalian cell cycle progression is highly dependent on the activity of CDKs due to 
their regulatory impact by phosphorylating key substrates (Santamaría et al., 2007). The 
concentrations of CDKs are relatively constant during the cell cycle, but the activity of 
this family of enzymes is highly dependent upon the expression levels of cyclins in the 
cell, and they are only active in their cyclin-CDK complex. Due to the variable expression 
of cyclins and their specificity towards binding CDKs (as each CDK can bind to a specific 
cyclin), they can be used as biomarkers during all stages of the cell cycle 





driven by the changing concentration of cyclins within the cell as cellular arrest occurs if 
an issue arises with production or degradation of these substrates (Malumbres and 
Barbacid, 2009).  
 
1.4.2 Cyclin-dependent Kinase 1 
 
Cdk1 is highly regulated as it functions in the irreversible transition of the cell from 
Interphase to mitosis. Due to the critical role of Cdk1 in this process, it is regulated 
through compartmental barriers, phosphorylation (at threonine 14 and tyrosine 15), and 
by the presence of Cyclin A and B (which can also be regulated through 
phosphorylation) (Potapova et al., 2009). Cyclin A remains associated with Cdk1 from 
late S into late G2-phase. The increase in cyclin B concentrations in the cytoplasm 
pushes the formation of cyclin B-Cdk1 complex leaving free cyclin A, which is degraded 
by ubiquitination(Fung et al., 2005). This event initiates prophase as more cyclin B-Cdk1 
complexes form. The complexes remain inactive as ATP orientation within the active site 
of the kinase is altered because the threonine 14 and tyrosine 15 residues have been 
phosphorylated by Wee and Myt kinases (Potapovaet al., 2009). The cyclin B-Cdk1 
complex is only in its active form after Cdc25 phosphatase dephosphorylates these two 
residues (Mailand et al., 2002). Cdc25 is regulated by phosphorylation via Polo-like 
kinases (Plks) (see below) as a further measure of mitotic regulation (Mailandet al., 
2002). 
 
Activated cyclin B-Cdk1 is located in the cytoplasm but the nucleus acts as a 
compartmental barrier, preventing it from phosphorylating its target substrates. Cyclin B-
Cdk1 complexes up-regulate their own transport into the nucleus as their overall 
concentration increases within the cytoplasm (Lindqvist et al., 2010). The entry of the 
complex may occur slightly before NEBD (Gavet and Pines 2010). Once in the nucleus, 
signal cascades result in spindle stabilization and elongation. Cyclin B-Cdk1 also 
increases expression of survivin and other key substrates that are critical for mitotic 
progression (Lindqvist et al., 2010). Knockdown of cyclin B, Cdk1 or cyclin B-Cdk1 
complex can result in cellular arrest or apoptosis due to low survivin levels, as well as 
cells having difficulty polarizing causing mitotic disarray (Castedo et al., 2002). Mitosis 
initiates with cyclin B-Cdk1 complex and the degradation of cyclin B at anaphase triggers 









1.4.3 Aurora and Polo-like kinases 
 
Polo-like kinases (Plks) are enzymes that play important roles in mitotic entry, exit, and 
spindle formation. They are shown to have high expression during mitosis and improper 
inhibition of this family of enzymes can lead to cellular apoptosis (Wang et al., 2002). 
Plks are characterized by highly conserved N-terminal serine/threonine kinase domains 
and polo-box domains (PBDs) at the C-terminus (Lee et al., 2014). One of the most 
studied members of the Plk family is Plk1. It participates downstream of mitotic entry due 
to its regulation of Cdc25 via phosphorylation, which leads to the activation of cyclin B-
Cdk1 (Lee et al., 2014). Plk1 has further involvement with mitotic spindles, centrosomes, 
and kinetochores, which makes it a key enzyme during mitosis (Jones et al., 2003).  
 
The mitotic progression and entry into cytokinesis is regulated by Aurora Kinases, a 
family of serine/threonine kinases (Fu et al., 2007). Three major Aurora Kinases in 
mammals are Aurora A, B, and C. Aurora A functions near the centrosomes activating 
cyclin B-Cdk1 by phosphorylating Cdc25B playing a key role in recruiting proteins 
responsible for the nucleation of microtubules (Marumoto et al., 2002). Aurora B is a 
subunit of the chromosomal passenger complex (CPC), which contributes to the 
progression of mitosis by orchestrating chromosomal alignment, cytokinesis, and the 
modification of histones (Vader et al., 2006) (Carmenaet al., 2013). Aurora C is shown to 
be versatile as it behaves like Aurora A during interphase and can compensate for low 





1.5 Cell Cycle Checkpoints 
 
Cells that undergo the cell-cycle must proceed in a regulated fashion to conserve the 





the cell cycle has gone through completion before initiating the next, the conditions of a 
cell cycle checkpoint must be met or cellular arrest may occur (Malumbres and Barbacid, 
2009). Improper bypass of these checkpoints can be intimately linked to psoriasis, 
neurocutaneousdisorders, and cancer (Malumbres and Barbacid, 2009).Three major 
checkpoints control the cell cycle. There are two non-mitotic checkpoints, which include 
the G1 to S-phase and G2 to M-phase checkpoints. The main mitotic checkpoint is the 
spindle assembly checkpoint (SAC) (Kastan et al., 2004). 
 
1.5.1 Spindle Assembly Checkpoint 
 
The spindle assembly checkpoint (SAC) is a surveillance mechanism that monitors 
chromosomes within the cell to ensure their proper segregation during mitosis. The core 
SAC proteins present in mammals are Mad1, Mad2, BubR1, Bub1, and Cdc20 (MCC 
complex) (Malmanche et al., 2006). SAC is activated if there are any errors in 
chromosomal attachment to the spindle apparatus. They have to be specifically attached 
in the proper orientation with the appropriate tension upon the sister centromeres to the 
extending microtubules from each spindle pole at the opposite ends of the cell (Lara-
Gonzalez et al., 2012). Unattached kinetochores prevent SAC inactivation and recruit 
open Mad2. Open Mad2 can bind with either Mad1 or Cdc20. The mechanism is 
believed to involve recruitment of Mad2 to Mad1 resulting in closed Mad2. This complex 
can interact allosterically with other open Mad2 proteins to increase its binding affinity to 
Cdc20 forming a closed Mad2-Cdc20 complex. The Mad2-Cdc20 complex inhibits 
Cdc20’s interaction with the anaphase promoting complex APC (Caldas and DeLuca, 
2013).  
 
The suppression of APC will inhibit anaphase onset and progression of mitosis. APC 
functions as a ubiquitin ligase that is responsible for the degradation of cyclin B which 
arrests the cell in mitosis (see below) (Fung et al., 2005). It also degrades securin 
resulting in the activation of separase that functions in cleaving the cohesion complex, 
separating the sister chromatids from each other (Fu et al., 2005). This ubiquitin ligation 
is mediated by the cofactor Cdc20 (Morgan et al., 2007).  
 
The SAC ensures that misaligned chromatids do not separate. One possible cause for 





SAC, the daughter cells may have unequal chromosomes (aneuploidy) that can result in 
neurological and neurodevelopmental diseases, and cancer (Poduriet al., 2013).  
 
1.6 Centromere Associated Protein E 
 
Centromere Associated Protein E (CENP-E) is a plus-end kinesin motor protein in 
mammalian cells that is responsible for chromosomal movement and spindle elongation. 
This protein functions in chromosome congression to the equator of the cell (Sardar et 
al., 2010). It consists of three major domains: a dimeric coiled coil intervening region, an 
amino-terminal motor domain, and a carboxy-terminal MT binding domain (Grancell and 
Sorger, 1998). The motor domain of CENP-E allows it to travel down MTs towards the 
KTs post-NEBD (Yao et al., 2000). The plus-end motor activity is fueled by ATP 
hydrolysis in prometaphase and only binds MTs at the surface of kinetochores in 
anaphase. CENP-E is located at the outer kinetochore extending about 100nm from its 
surface and remains there throughout the rest of the phases in mitosis. It binds to MTs at 
the surface of KTs with its MT-binding domain (Musinipally et al., 2013). Unlike typical 
plus end-directed kinesins, CENP-E also transitions in a minus-direction. The minus-
directed transition of mono-oriented chromosomes towards the metaphase plate is 
achieved by spindle depolymerization that is fueled by GTP hydrolysis (Grancell and 
Sorger, 1998). However, depletion of CENP-E does not hinder chromosomes from 
transitioning to the spindle equator. Even though chromosomal transition is not arrested, 
the loosely bound MTs to their KTs do increase the chances of chromosome mis-
segregation (Putkey et al., 2002) and aneuploidy in daughter cells (Kim et al., 2008). 
This suggests that CENP-E functions in KT-MT binding.  
 
During metaphase CENP-E functions at the level of the SAC. Its conformational changes 
at the surface of the KT can cause SAC amplification by interacting via its motor domain 
with BubR1. This interaction enhances the autophosphorylation activity of BubR1 which 
is important for the attachment of MT to KT (Foltz et al., 2006). The enhancement of 
BubR1 kinase activity by CENP-E is not critical to the progression of mitosis since 
CENP-E depletion does not result in the inhibition of APC (Zhao et al., 2011). The 
activity of BubR1 decreases to basal levels without causing mitotic arrest at anaphase 





unattached KTs present. If one KT is unattached in HeLa cells, mitotic arrest does not 
occur. Once 7 unattached KTs are present in HeLa cells, mitotic arrest occurs as CENP-
E can form a ternary complex with BubR1 and can silence its kinase activity (Mao et al., 
2005). This interaction activates the mitotic checkpoint complex, resulting in the 
inhibition of APC (Guo et al., 2012). Xenopus extracts have resulted in no mitotic arrest 
through this mechanism (Weaver et al. 2003) making this process cell-type dependent. 
TABLE 1.1: 
 
Mammalian and yeast TRAPP subunit nomenclature  
S. cerevisiae TRAPP subunit (KDa) Mammalian TRAPP subunit (KDa) 
                      Bet5p (18)                     TRAPPC1 (17) 
                      Tca17p (17)                     TRAPPC2L (16) 
                      Trs20p (22)                     TRAPPC2 (16) 
                      Bet3p (22)                     TRAPPC3, TRAPPC3L (20) 
                      Trs23p (23)                     TRAPPC4 (24) 
                      Trs31p (31)                     TRAPPC5 (21) 
                      Trs33p (33)                     TRAPPC6a,b (19,15) 
                      Trs65p (65)  
                      Trs85p (85)                     TRAPPC8 (161) 
                      Trs120p (120)                     TRAPPC9 (140) 
           Trs130p (130)                     TRAPPC10 (142) 
                     TRAPPC11 (129) 
                     TRAMM (79) 
                     TRAPPC13 (40) 
Proteins on the same row indicate homologues; empty cells indicate no 
homologues detected in databases. 









Project: Cdk1 has a role in phosphorylating TRAMM 
 
TRAMM was originally identified as a protein that co-precipitates with the TRAPP 
(transport protein particle) complex that functions in membrane trafficking. Recent work 
in our laboratory suggested a role for this protein in mitosis, specifically in chromosome 
congression prior to metaphase (Figure 1.1(A), Figure 1.1(C)). In early stages of mitosis, 
TRAMM is post-translationally modified by phosphorylation (Figure 1.1(B)). Knockdown 
of the protein causes it to affect the localization of various kinetochore proteins with the 
strongest effect on CENP-E. The two proteins were shown to interact in vitro using a 
yeast two hybrid assay (Milev et al., 2015). 
 
In this study, I will use a co-immunoprecipitation assay to check whether the in vitro 
interaction between TRAMM and CENP-E also occurs in vivo. Using various inhibitors of 
mitotic kinases, I will identify the kinase responsible for the phosphorylation of TRAMM. 
Furthermore, I will also use bioinformatics tools to predict and analyze the structure of 
TRAMM. Finally I will express and purify the recombinant form of TRAMM in a 
homogeneous monodispersed protein sample as an initial step towards future structural 
analysis via crystallization. This study will allow us to better understand the unique role 


















Chapter 2: Materials and Methods 
 
2.1 Buffers and solutions  
 
All buffers and solutions used in this project are listed in Table 2.1 at the end of the 
Materials and Methods section.  
 
2.2 Protein analysis techniques  
 
2.2.1 Protein expression and purification:  
  
E. coli Arctic Express ® cells were transformed with a recombinant form of TRAMM that 
was inserted into pDEST-17 plasmid (containing a 6x His tag). The cells were grown at 
37°C overnight on Luria Bertani (LB) agar plates supplemented with 
ampicillin (amp) (100 mg/mL). A single colony was used to inoculate a 20 mL starter 
culture of LB+amp media that was incubated with shaking at 37°C overnight. 500 mL 
of LB+amp media was inoculated with the starter culture (with or without 10 mM MgCl2), 
then incubated at 30°C with shaking until the OD at 600 nm reached 0.7-0.8. Expression 
of recombinant TRAMM was then induced by addition of IPTG (Isopropyl β-D-1-
thiogalactopyranoside) to a final concentration of 1 mM. After 24 hours shaking at 12°C, 
cells were harvested by centrifugation at 10,000 × g for 10 min at 4°C. Pellets containing 
recombinant TRAMM were re-suspended in 35 mL of lysis buffer containing 7µl of 0.5 M 
AEBSF (protease inhibitor). This was followed by programmed sonication (10 sec 
on/10 sec off for 2 minutes). Lysates (with or without 5 units of DNAse I 
from Thermo Scientific Lot 00152435) were cleared at 30,000 × g for 30 min at 
4°C. During this time the Ni2+-beads were prepared as follows. A 50% slurry of nickel 
beads was resuspended in lysis buffer. The mixture was centrifuged at 270 × g for 2 
minutes at 4°C. The buffer was aspirated leaving a small volume above the beads. After 
3 washes, the beads were resuspended in lysis buffer and added to the 
supernatant obtained as described above. Note that 500 µL of washed nickel beads, 
which is equivalent to 1 mL of 50% slurry solution were incubated with each sample for 1 
h. The mixture was passed through a gravity column to collect the beads and the column 





buffer. TRAMM was eluted by incubation for 5 minutes with 0.5 mL elution buffer before 
being collected.   
  
2.2.2 Co-immunoprecipitation (IP):   
 
For each sample, 1 mg of HeLa cell lysate (collected from a 10 cm dish) was mixed with 
2 µg of anti-GFP IgG and incubated for 2 h on ice. During this time Protein-G agarose 
beads were prepared as follows. A 50% slurry solution of protein-G agarose beads 
was resuspended in lysis buffer then centrifuged for 30 seconds at 5000 rpm at 4°C. The 
supernatant was removed without disturbing the pellet that contains the beads. The 
washing process was repeated three times before the beads were re-suspended 
in PBS and added to the samples (10 µl of beads per sample, which is equivalent to 20 
µl of 50% slurry solution). The mixture was left shaking for 1 hour at 4°C. The beads in 
the mixture were washed with lysis buffer 3 times. After the last wash was 
completed and the buffer was aspirated, 20 µL of 1x sample buffer containing 5% BME 
(B-mercaptoethanol) was added and the sample was incubated at 96°C for 2 minutes. 
Before freezing at -20ºC, the beads in the sample were pelleted at 13000 rpm for 2 
minutes.   
  
2.2.3 Mass spectrometry:  
  
After His-tagged TRAMM was purified and subjected to SDS PAGE, the Coomassie blue 
stained gel was rinsed with MilliQ H2O. The desired band was excised with a clean 
scalpel and diced into small pieces. Coomassie destaining was performed by the 
addition of 100 µL of NH4HCO3 in 50% methanol. The mixture was centrifuged briefly 
and the supernatant was discarded. 100 µL of 100% acetonitrile (ACN) was added to the 
gel particles and the mixture was incubated for 5 minutes with occasional mixing. The 
mixture was centrifuged and the supernatant was discarded. Gel particles were covered 
with 100 µL of 10 mM DTT and the mixture was incubated at 50°C for 30 minutes. Brief 
centrifugation was performed and the liquid was discarded. The particles were alkylated 
by the addition of 100 µL of 55 mM iodoacetamide. After 30 minutes of incubation at 
room temperature, the mixture was centrifuged and the liquid was removed. The 
particles were dehydrated using 100 µL ACN and dried in a speed vac for 





ng/µL trypsin for 10 minutes with occasional vortex mixing. Excess trypsin was removed 
and 30 µL of 50mM NH4CO3 was added. The mixture was incubated for 18 hours at 
37°C to allow for protein digestion. 50 µL of H20 was added to each sample and the 
mixture was vortexed for 2 minutes, and then centrifuged at 5000 rpm for 30 
seconds. The supernatant containing tryptic peptides was transferred to a newly labeled 
tube. The volume was reduced to 15 µL using a speed vac. Samples were cleaned 
using a C18 ziptip (Millipore) and subjected to HPLC-MS. For HPLC a Spursil Column 
C18, 3mm particle size, 150mm long, 2.1mm diameter from Agilent model 1200 was 
used. For mass spectrometric analysis the sample was injected into a Waters QTOF3 
(also known as an Ultima) at a mass range of 400Da to 2000Da with a dissolving 
temperature of 300°C at a flow rate of 10µL/min.   
 
2.2.4 Dynamic Light Scattering:   
 
Purified recombinant His-tagged TRAMM protein was subjected to size 
exclusion chromatography (described in 2.2.8) and 0.5mL fractions were 
collected. The fractions that represented the TRAMM peak (fractions 20-25) were 
combined to reach a volume of 2.5mL. The mixture was concentrated by using 
an Amicon ultra-4 centrifugal filter unit that was centrifuged at 4000 × g for 5 minutes at 
25°C to obtain a final volume of 50 µL. The mixture was then filtered with a 0.45-
micron filter syringe. The filtered solution was subjected to dynamic light scattering 
using a DynaPro Nanostar instrument at 25°C and laser power of 100 crescents.     
 
2.2.5 Bradford Assay:   
 
Using Ultrospec 2100pro spectrophotometer at 595 nm, a standard calibration curve was 
prepared from known quantities of BSA. Five different points were used in each standard 
curve corresponding to 1,2,4,6 and 10 µg of BSA. 10 µL of the protein sample was 
diluted with 1 mL of Bradford reagent. The protein sample concentration was determined 
by comparison with the standard curve at an OD of 595 nm.   
  
2.2.6 Western blotting:   
 





gels at 120V. Proteins were transferred to nitrocellulose membranes for 1 h at 100 V in 
cold transfer buffer. The membranes were blocked with 5% skim milk for 1 hour and 
then incubated with primary antibody in PBSt (concentrations mentioned in the antibody 
section below) for 2 hours. After 3 washes with PBSt for 5 minutes each, the membranes 
were incubated with the secondary antibody (anti-mouse or anti-rabbit conjugated to 
horseradish peroxidase) at a dilution of 1:10000 for 1 hour. Finally, ECL reagent 
(Amersham Life Science) was added in the dark room and incubated with the membrane 
for 2 minutes and then exposed to photographic film at different time exposures (1 sec–
15 min) to produce the desired exposure.     
 
2.2.7 Size exclusion chromatography:   
 
Recombinant His-tagged TRAMM protein was purified as described above and 100 µg of 
the 150 mM imidazole elution was loaded onto a Superpose 6 column and fractionated 
in gel filtration buffer at a rate of 0.5 mL/min. Fractions of 0.5 mL were collected and 
resolved by SDS-PAGE and Coomassie blue staining.   
  
2.3 Tissue culture techniques   
  
 2.3.1 Cell culture:   
 
HeLa or HEK293T cells were grown in Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS) at 37°C in a humidified incubator with 
5% CO2. Cells were either asynchronously growing or synchronized at different stages of 
the cell cycle as described below.  
  
 2.3.1.1 Double thymidine treated cells:   
 
HeLa cells plated at 25-30% confluency (300,000-350,000 cells per 10 cm dish) were 
treated with 2 mM thymidine for 18 hours, washed 2 times with PBS, and then released 
into medium for 6 hours. HeLa cells were subjected to another treatment of 2mM 
thymidine for 16 hours before they were either harvested or released into DMEM.  





 2.3.1.2 Nocodazole treated cells:   
 
After 3 hours of the second thymidine release (as mentioned above), 100 ng/mL 
of Nocodazole was added into the medium. After 9 hours of the nocodozole treatment, 
cells were treated with one of the following kinase inhibitors: 100 nM BI-2536 (a Plk1 
inhibitor), 2 µM ZM-44743 (an Aurora A, B, C inhibitor), 9 µM R0-3306 (a Cdk1, 2 
inhibitor), or left untreated before cells were harvested at different time points as 
mentioned in the results (section 3.2).   
 
 2.3.1.3 Colcemid treated cells:   
 
When HeLa cells (plated on a 10 cm dish) reached 80% confluency, they were 
treated with 5 µg/mL of colcemid for 17 hours before they were washed 3 times with 
PBS before harvesting.   
  
 2.3.2 HeLa cells harvesting:   
 
Mitotic cells treated with colcemid or nocodazole were directly collected in 
the medium since they were easily removed from the plastic dishes. Non-mitotic cells 
were trypsinized for 2 minutes after which the cells were washed with PBS. Both mitotic 
and non-mitotic cells were pelleted at 1900 rpm for 2.5 minutes at 4°C, and washed with 
PBS before they were pelleted again and finally lysed with lysis buffer. Cells were stored 
at -20°C until they were subjected to western blots.   
  
 2.3.3 Lambda phosphatase treatment:   
 
HeLa total cell lysates were centrifuged at 16000 rpm for 20 minutes at 4°C to remove 
the cell debris. Cell extracts were incubated for 2 hours at 30°C with Lambda 
phosphatase solution (containing 400 units of Lambda phosphatase, 1x NEBuffer for 
protein metallophosphatases and 1mM MnCl2) from Bio England Biolabs (P0753S). The 
reaction was terminated by the addition of 4x SDS sample buffer followed by boiling for 2 









Table 2.1 List of buffers and solutions used in this study 
 
Reagent name Components 
 
Nickel-bead purification lysis 
buffer 
 
50mM Tris-base pH 8.5, 5% v/v glycerol, 1% Triton X-100, 0.3M NaCl, 
10mM BetaMercaptoethanol 
Nickel-bead purification wash 
buffer 
50mM Tris-base pH 8.5, 200 mM NaCl, 5mM imidazole 
Nickel-bead purification elution 
buffer 
50mM Tris-base pH 8.5, 1mM BME, 200 mM NaCl, 50-200 mM imidazole 
PBS 0.061% w/v Na2HPO4, 0.8% w/v NaCl, 0.02% w/v KCl, 0.02% w/v 
KH2PO4 pH 7.3 
PBSt PBS with 0.1% v/v Tween-20 
4x sample buffer 80 mM Tris-HCl pH 6.8, 0.1% bromophenol blue, 5% v/v 
Betamercaptoethanol, 10% v/v glycerol, 2% w/v SDS 
SDS-PAGE running buffer 25mM Tris-base, 200mM glycine, 0.1% SDS 
Western blotting transfer 
buffer 
Tris-base, 200mM glycine, 25mM, 20% methanol 
Mammalian cells lysis buffer 50mM Tris-base pH 7.2, 1% Triton X- 100(v/v), 0.5mM EDTA, 1mM DTT, 
150mM NaCl, 2 tablets of Phospho-Stop (Roche) per 10mL, 1 tablet of 
protease inhibitor cocktail (Roche). 
Gel filtration buffer 50mM Tris-base pH 7.2, 0.5mM EDTA, 150mM NaCl 

































Table 2.2   List of antibodies used in this study  
  















Phospho-histone H3 M m 1:1,000 17 3377 Cell Signaling 
TRAMM P m 1:1,000 78 Ab27076 Abcam 
TRAMM P r 1:1,000 78 N/A Sacher laboratory 
Tubulin M m 1:5,000 50 Ab27076 Abcam 
GFP M m 1:1,000 27 Ab1218 Abcam 
Protein sizes are indicated in kilodaltons. M, monoclonal; P, polyclonal; N/A, not applicable; r, rabbit; m, 








Chapter 3: Results 
 
3.1 TRAMM associates directly or indirectly with CENP-E in vivo 
 
TRAMM plays a role in mitosis and its depletion results in a chromosome 
congression failure. This is caused by the mislocalization of some kinetochore proteins 
and the strongest effect was seen for CENP-E. Results of this yeast two-hybrid assay 
suggested a direct interaction between TRAMM and CENP-E (Milev et al., 2015). 
 
To confirm that the interaction that was seen by yeast two-hybrid also occurs in vivo, 
lysates prepared from human embryonic kidney (HEK293T) cells stably expressing 
GFP-tagged CENP-E were used for Co-IPs. HeLa cells were used as negative controls. 
Reasoning that the expression of CENP-E increases during mitosis (as compared to 
interphase cells) (Testa et al., 1994), lysates from asynchronous cells 
or colcemid treated (mitotic) cells were incubated with anti-GFP to precipitate CENP-E 
and then probed for TRAMM. As compared to the control HeLa cells, a greater amount 
of TRAMM co-precipitated with CENP-E indicating that it associates with CENP-E 
directly or indirectly in vivo (Figure 3.1). More interestingly, this association increased in 
mitotic cells when compared to interphase cells. This result is consistent with the yeast 
two-hybrid result showing that TRAMM does not only interact with CENP-E in vitro, but 















Figure 3.1 TRAMM associates directly or indirectly with CENP-E invivo. 
Bacterial artificial chromosome (BAC) cell line expressing CENP-E-GFP in HEK293T 
and HeLa cells (negative control) were co-immunoprecipitated using GFP antibody. The 
left panel represents 10% of the inputs and right panels represents the IPs. Cells were 
either left asynchronous (A) or treated with colcemid (Col) to arrest cells in mitosis. 



















3.2 Phosphorylation of TRAMM is Cdk1 dependent 
 
TRAMM is phosphorylated early in mitosis and dephosphorylated at the onset of 
anaphase. This phosphorylation leads to the appearance of a slower migrating doublet 
at ~83 KDa as compared to a faster-migrating band at ~79 KDa of non-
phosphorylated TRAMM (Milev et al., 2015). In order to determine the kinase 
responsible for phosphorylating TRAMM during mitosis, we focused on the three main 
mitotic kinase families: Cdks, Aurora kinases, and Plks. 
 
HeLa cells were arrested at the G1/S boundary by thymidine treatment and then 
released into medium containing nocodazole (to arrest the cells at 
prometaphase). HeLa cells were then treated with BI-2536 (a Plk1 
inhibitor) in Figure 3.2(A), ZM-44743 (an Aurora A, B, C inhibitor) in Figure 3.2(B), R0-
3306 (a Cdk1, 2 inhibitor) in Figure 3.2(C), or left untreated in Figure 3.2(D). Figure 
3.2 shows the results of HeLa cells that were collected at various times following double 
thymidine release, lysed and subjected to western blots. Samples were probed for 
TRAMM, phospho-Histone 3 (mitotic marker), and Tubulin (loading 
control). HeLa cells that were collected 3h following the release from double 
thymidine treatment showed no signs of phosphorylation because the cells were still in 
interphase (phospho-H3 is absent). At 11h following release, HeLa cells showed a 
slower migrating form representing the phosphorylation of TRAMM during 
mitosis (phospho-H3 is present). When the cells were only treated with nocodazole 
(control condition), the phosphorylation of TRAMM was present from 11h to 13h (Figure 
3.2(D)). Similar results were seen in Figure 3.2(A) and Figure 3.2(B) upon the treatment 
with BI-2536 and ZM-447439, respectively. In contrast, when HeLa cells were treated 
with RO-3306 TRAMM was phosphorylated at 11h but not at subsequent time points 
(Figure 3.2(C)). The dephosphorylation that occurred in the presence of 
the Cdk inhibitor but not in the presence of the Plk or Aurora kinase inhibitors suggests 
that phosphorylation of TRAMM at mitosis is Cdk-dependent. At a concentration of 9 µM, 
RO-3306 inhibits Cdk1 and Cdk2. Cdk2 is mainly involved in interphase while Cdk1 is 
one of the main protein kinases orchestrating mitosis. This strongly suggests that 








Figure 3.2 Phosphorylation of TRAMM is Cdk1 dependent. Western blot analysis of 
HeLa cells collected at different time indicated in hours after double thymidine treatment. 
Note that all blots were subjected to the same exposure time. As indicated in materials 
and methods section cells were treated with various mitotic protein kinase inhibitors after 
11h of the second thymidine release: A) BI-2536 (Plk1 inhibitor); B) ZM0447439 (Aurora 
A,B,C inhibitor); C) RO3306 (Cdk1,2 inhibitor); D) no inhibitor was added. Antibodies 















3.3 Prediction of the structure of TRAMM and possible phosphorylation sites 
 
Solving the structure of TRAMM is an important step to determining its 
function (Freeman et al., 2002). However, in the absence of the structure, bioinformatics 
tools can give us some limited information on TRAMM. According to UniProt database 
TRAMM contains 4 distinct TPR repeats in the carboxy half of the protein (Figure 3.3 
(A)) and 12 overlapping TPR domains according to KEGG database (Figure 3.3(B) and 
Figure 3.3(C)). The Tetratricopeptide repeat (TPR) domain is a structural motif that 
consists of degenerate 34 amino acid repeats. These alpha helix pair repeats fold 
together forming scaffolds to mediate protein-protein interactions (Blatch et al., 
1999). Interestingly, other cell division proteins such as APC subunits including cdc16 
and cdc23 contain TPR motifs for their unique functions in facilitating protein-protein 
interactions, and the assembly of multiprotein complexes (Passmore et al., 
2005). Phyre 2 database was also utilized for performing the structural analysis of 
TRAMM. According to Phyre 2, the secondary structure showed 53% unstructured 
regions, 44% structured helices and 1% β strands. Moreover, tertiary structural 
analysis (Figure 3.4(A)) revealed that the TPR domains are exposed and not shielded by 
the amino terminus, thus facilitating protein-protein interactions. As mentioned above, 
TRAMM is predicted to be largely unstructured and studies have shown that 
unstructured regions are often involved in posttranslational modifications, such as 
phosphorylation (Dyson et al., 2005). 
 
I next sought to determine which sites of TRAMM are potenitally phosphorylated during 
mitosis. Uniprot database revealed 2 possible phosphorylation sites: 109 and 184 
(Figure 3.3(A)). To precisely predict the possible sites of phosphorylation, 
several phosphoproteomic studies (Milev et al., 2015; Dephoure et al., 2008; Kettenbach 
et al., 2011; Mayya et al., 2009) were mined for TRAMM phosophorylation (Figure 
3.4(B)). This revealed 5 sites of phosphorylation that occur in vivo. Consistent with 
results from Figure 3.4(A), Figure 3.4(B) predicts amino acids 109 and 184 as possible 
sites of phosphorylation and adds 3 extra possible phosphorylation sites: 107, 127 and 
182. All 5 sites of phosphorylation: 107, 109, 127, 182 and 184 are located in the 
unstructured N-terminal portion of the protein. Now that I have determined the 5 possible 
sites of phosphorylation, I checked whether any of these sites contain Cdk1 consensus 





to the Cdk1 consensus motif (S/T P). This is consistent with the results shown 








Figure 3.3 (A) Schematic representation of TRAMM’s conserved motifs extracted 
from Uniprot database. Table 3.1 and Figure 3.3 (B) Conserved motifs extracted 
from KEGG analysis. 
 
Phosphorylation sites identified in TRAMM 
Residue Peptide Source 
T107 PEPAGTPSPSGEAD Milev et al., 2015; Dephoure et al., 2008 
S109 PEPAGTPSPSGEAD Milev et al., 2015; Dephoure et al., 2008 
S127 DAAPSSGGAPR Milev et al., 2015; Dephoure et al., 2008 
S182 PQMVKSPSFGGAS 
Milev et al., 2015; Mayya et al., 2009;  
Kettenbach et al., 2011 
S184 PQMVKSPSFGGAS 
Milev et al., 2015; Dephoure et al., 2008;  
Mayya et al., 2009 
B 
 
Figure 3.4 Prediction of TRAMM tertiary structure and possible phosphorylation 
sites. (A) Tertiary structure prediction from Phyre 2 showing unstructured region in 
green, helices in red and TPR repeats in pink. (B) Possible phosphorylation sites of 






3.4 Optimization of TRAMM recombinant protein purification 
 
One way to address the function of TRAMM is to determine its three-dimensional 
structure by techniques such as small-angle x-ray scattering, nuclear magnetic 
resonance or X-ray crystallography. The first step towards elucidating the three-
dimensional structure is purifying the protein of interest. Such a protein could also be 
used for generating anti-TRAMM antibody. Moreover, the purified protein could be used 
in an in vitro kinase assay to confirm that Cdk1 has a role in phosphorylating TRAMM 
(section 3.2). Recombinant TRAMM was expressed in BL21 (DE3) cells but the protein 
was found to be in the insoluble fraction. Reasoning that proteins tend to fold better at 
lower temperatures, I next tried to express the protein in Arctic Express (DE3)® cells. 
These cells were used since they contain two low-temperature chaperones (Cpn10 and 
Cpn60) to aid in protein folding. The expression and purification of TRAMM in Arctic 
Express cells, resulted in the presence of two bands as shown in Figure 3.5(A): a slower 
migrating polypeptide that was at the molecular size of TRAMM (79 KDa) and a faster 
migrating species. The two bands were excised, trypsinized and subjected to mass 
spectrometry. Mass spectrometry results of the slower migrating polypeptide are shown 
in Figure 3.6(A). Peaks were collected and graphs representing M/Z versus intensity 
(data not shown) were utilized to conclude the mass of fragmented peptides. Utilizing the 
masses of the fragmented peptides, and with the help of database searches, this 
polypeptide was identified as our protein of interest, TRAMM. Mass 
spectrometry also revealed that the faster migrating species was an undesired bacterial-
expressed contaminant belonging to the ArnA gene (data not shown). The issue of 
contamination was addressed by the treatment with divalent cations (MgCl2) (based 
on personal communication with Eduardo A. Ceccarelli on ResearchGate) that had the 
ability to suppress the expression of ArnA in E. coli. This resulted in the purification of 
just the TRAMM protein (Figure 3.5(B)). However, this treatment led to the appearance 
of a smear on the top of our band of interest. Due to its high molecular weight and 
smeary appearance, it was suspected to be DNA. Therefore, lysates were treated 
with DNAseI. The combination of MgCl2 and DNAseI treatments resulted in a clear single 
band (Figure 3.5(C)). 
 





protein sample to confirm the mass spectrometry results. Figure 3.6(B) shows that anti-
TRAMM was specifically binding to the protein sample, which resulted in a 79 kDa band 
corresponding to the molecular size of TRAMM). This band was absent in the negative 
control (bovine serum albumin). All together mass spectrometry, as an unbiased 
technique, and western blotting conclude that the purified protein sample is TRAMM. 
 
The purified protein was used for generating an anti-TRAMM antibody, which was 
utilized for probing all subsequent western blots. The homemade antibody recognizes 
the same polypeptide as the commercial anti-TRAMM antibody, where it is able to detect 
TRAMM in its phosphorylated state (HeLa cells treated with colcemid but not lambda 
phosphatase) and non-phosphorylated form (Lambda phosphatase 























Figure 3.5 SDS-PAGE followed by Comassie bleu staining of purified TRAMM. (A) 
Purification process was done in the absence of MgCl2, showing TRAMM (the higher 
band) and another undesired polypeptide. (B) Purification process was done the 
presence of MgCl2, but without DNAse treatment showing a smear on the top of the 
band. Lanes (1), (2) and (3) represent different elutions with 150mM imidazole elution 
buffer. (C) Purification process was in presence of MgCl2 and DNAse. Lanes (1), (2) and 











Figure 3.6 Confirmation of TRAMM and antibody production. (A) Mass spectrometry 
data showing data showing the variation of time as function of the intensity of 
fragmented peptides. (B) Western blot probed with anti-TRAMM for protein sample and 
negative control BSA (Bovine serum albumin). (C) Western blot of asynchronous, 
colcemid treated and thymidine arrested HeLa cells. HeLa cells were either treated with 









3.5 Recombinant purified TRAMM protein analysis by dynamic light scattering 
 
The polydispersity of a protein sample represents the protein’s particle size distribution 
width. A protein sample with less than 20% polydispersity is considered to be 
monodispersed (Price et al., 2009). Figure 3.7(A) represents the initial observation 
of the dynamic light scattering (DLS) of a TRAMM protein sample, showing 2 peaks at 
3x106 counts/sec with radius R=39.5nm and R=107.6nm, respectively. This result does 
not represent a protein of molecular weight= 79KDa. The R is too large and the counts 
are too high. To address this problem the buffer containing TRAMM was changed by 
fractionating the sample on a size exclusion (Superpose 6) column removing B-
mercaptoethanol and imidazole. Fractions collected from the size exclusion column were 
subjected to SDS-PAGE and Coomassie blue staining (Figure 3.7(B), top panel) 
revealing a band at the desired molecular size of TRAMM, mainly in fractions 20-25. 
These fractions were combined and concentrated, and then analyzed by DLS. The 
resulting sample was at 27.4% polydispersity, which is still considered to be a 
polydispersed sample >20% polydispersity, as shown in Figure 3.7(C). Reasoning that 
the elution by size exclusion chromatography was occurring at a size greater than that 
expected for a 79kDa polypeptide, we suspected the presence of high molecular weight 
particles in the solution besides TRAMM. For the purpose of removing the undesired 
high molecular weight particles from the solution; the sample from Figure 3.7(C) was 
filtered using a 0.45 micron filter to yield the solution analyzed in Figure 3.7(D). Results 
in Figure 3.7(D) yielded 16.5% polydispersed species at R=15.4nm that is reasonable 
for a 79KDa protein. The monodispersed protein (<20% polydispersity) obtained from 
Figure 3.7(D) was subjected to western blotting and probed with the homemade anti-
TRAMM antibody. While the negative control (purified TRAPPC2) did not show any band 
at 79 KDa, the purified sample showed a clear band of the expected size (Figure 3.7(B), 
bottom panel), confirming that the monodispersed protein analyzed in Figure 3.7(D) is 
TRAMM. As a result, Figure 3.7 shows successful optimization and transition 
of the polydispersed protein sample of purified TRAMM to a monodispersed protein 
sample. A monodispersed protein sample is a strong indicator of successful 











Figure 3.7 Recombinant purified TRAMM protein analysis by dynamic light 
scattering. (A) Graph representing DSL results of purified TRAMM protein sample in its 
initial elution buffer. (B) Top: Size exclusion chromatography of purified recombinant 
TRAMM. Eluted protein at 150mM imidazole was fractionated on Superpose 6 size 





indicated on top; bottom panel: Western blot probed  with anti-TRAMM for TRAMM 
protein sample (after changing the buffer and filtering the sample using 0.45 micron filter 
as described in materials and methods section 2.2.5) and negative control TRAPPC2. 
(C) Graph representing DSL results of purified TRAMM protein sample in elution buffer 
without DTT and imidazole. (D) Graph representing DLS results of purified TRAMM 

































Chapter 4: Discussion 
	  
The TRAPP complex was initially discovered as a tethering factor involved in membrane 
trafficking (Sacher et al., 1998). Recent work in our laboratory suggests that TRAMM is 
involved in mitosis (Milev et al., 2015). Size exclusion chromatography of HeLa cells 
revealed that TRAMM, which belongs to the TRAPP complex during interphase, 
dissociates from the complex and shifts to lower molecular size fractions during mitosis. 
The mechanism by which TRAMM dissociates from the TRAPP complex during mitosis 
is still unclear. In mitosis, TRAMM is post-translationally modified by phosphorylation 
(Milev et al., 2015). Phosphorylation can cause conformational changes that could affect 
protein-protein interactions and thus allow proteins to be dissociated from their 
complexes (Nishi et al., 2011). This would provide a mechanism for TRAMM to perform 
its role during mitosis and to dissociate from the TRAPP complex. Alternatively, TRAMM 
could dissociate from the complex by a different mechanism, which is independent of the 
phosphorylation. Interestingly, TRAMM-5D (a phosphomimetic mutant that contained all 
five potential phosphorylation sites changed to aspartic acid residues) was able to recruit 
more CENP-E to the kinetochores than TRAMM-5A (a mutant that had all five 
phosphorylation sites changes to nonphosphorylatable alanine residues). As compared 
to TRAMM-5A, TRAMM-5D showed a reduced ability to suppress the increase in mitotic 
index induced by TRAMM depletion. These results could suggest that although the 
phosphorylation of TRAMM is not necessary, it needs to be reversible for proper 
function. In this study, I show that Cdk1 is most likely the kinase responsible for the 
phosphorylation of TRAMM. The dephosphorylation observed when Cdk1 was inhibited 
could be explained by the fact that in mitosis there is a balance between kinases and 
phosphatases. It is this balance that orchestrates the cell cycle and allows the cell to 
progress throughout mitosis (Barr et al., 2011). Upon altering the kinase-phosphatase 
equilibrium by inhibiting Cdk1, which is the kinase responsible for phosphorylating 
TRAMM, the corresponding phosphatase would be capable of dephosphorylating 
TRAMM.  
    
Several facts could support that TRAMM is phosphorylated by Cdk1. Cdk1 is a major 
mitotic kinase that phosphorylates more than 200 cell cycle related proteins mainly 





(Errico et al., 2010; Ubersax et al.,2003). In parallel with the activity of Cdk1, TRAMM is 
phosphorylated as the cell enters mitotis and dephosphorylated as the cell enters 
anaphase in parallel with degradation of cyclin B-Cdk1 (Milev et al., 
2015). TRAMM also contains the Cdk1 consensus motif in 3 out of its 5 predicted 
phosphorylation sites. Moreover, per Phosphokinase 3.1 kinase prediction, Cdk1 was 
one of the possible kinases at site 182 with p>0.5. For confirming that Cdk1 is the kinase 
responsible for phosphorylating TRAMM, purified Cdk1 was incubated with recombinant 
purified TRAMM in the presence of ATP (without the use of radioactive labeling). 
TRAMM’s molecular weight is expected to shift in the presence Cdk1 due to 
phosphorylation. Inconclusive results were obtained as western blots showed that 
TRAMM’s molecular weight was identical in the presence and absence of Cdk1(results 
not shown). For future work, this experiment could be repeated by incubating purified 
Cdk1 with purified TRAMM in the presence of gamma labeled ATP to produce a clear 
and consistent result where TRAMM is expected to be radiolabeled. 
    
TRAMM is among various proteins such as Aurora B and BubR1 which affect CENP-E 
localization to the kinetochores (Liu et al., 2007; Putkey et al., 2002). It is noteworthy that 
when compared to other proteins, TRAMM has the most dramatic effect on the 
localization of CENP-E. CENP-E and TRAMM co-localize early in mitosis when TRAMM 
is maximally phosphorylated. Upon depletion of CENP-E, some chromosomes are 
improperly attached to the microtubules and are incapable of aligning at the metaphase 
plate (Milev et al., 2015). This resembles the phenotype of TRAMM depletion (Yao et al., 
2000), suggesting that there is a strong link between CENP-E and TRAMM. This link 
was further confirmed by a yeast two-hybrid interaction that clearly suggests that the two 
interact in vitro (Milev et al., 2015). Further investigation in this study showed that the 
two do not only interact in vitro but also associate in vivo. However, this result was 
irreproducible, which could be due to the weak and transient association between 
CENP-E and TRAMM. Further investigation is needed to confirm this interaction in vivo. 
This could include epitope tagging of TRAMM and creating a stable cell line expressing 
the tagged form of TRAMM. Precipitating TRAMM in mitotically arrested cells and using 
mass spectrometry or western blot would confirm whether CENP-E is among the 
interactors.  
    





in mitosis. Upon analyzing the secondary structure by bioinformatics, the presence of 4 
TPR motifs in the C-terminal portion of the protein was identified. Since this motif is 
involved in protein-protein interactions, it is tempting to speculate that this domain binds 
to CENP-E. In addition, the amino-terminal portion of the protein is predicted to be 
mainly unstructured. This same region contains the 5 residues involved in 
phosphorylation.  
    
In the absence of a structure for TRAMM, the understanding of the mechanism of its 
function is limited. To overcome this issue, efforts were made towards producing a 
protein suitable for structural studies. I purified the recombinant form of TRAMM by 
expressing it in Arctic Express cells. Arctic Express cells possess Cpn10 and Cpn60 
chaperonins that could help fold the protein of interest at cold temperatures. As such, 
this allowed recombinant TRAMM to be expressed as a soluble protein, a necessary first 
step in any structural study. To determine the importance of the unstructured N-terminal 
region on both the nature and structure of TRAMM, a truncated construct of TRAMM 
(missing the N-terminal unstructured domain) was expressed in Arctic Express cells 
(results not shown). TRAMM was expressed in a soluble form, but was not eluting from 
the column, suggesting that the solubility of TRAMM was affected. This is consistent with 
unpublished results showing that truncated TRAMM at the N-terminal could not rescue 
and suppress TRAMM knockdown-induced mitotic arrest. Moreover, 
a phosphomimetic mutant that contained all five potential phosphorylation sites changed 
to aspartic acid residues was expressed in Arctic Express cells (results not shown). 
Once again, the solubility of TRAMM was altered and it was not eluting from the column 
despite its presence in both the total cell lysate and the supernatant. All together this 
could suggest that the folding of the unstructured N-terminal portion containing the 
phosphorylation sites could be altered during mitosis to help regulate the function of 
TRAMM.  
    
The monodispersed purified TRAMM sample is a strong indicator of successful 
crystallization of TRAMM. To date, 6 mammalian TRAPP subunits (TRAPPC1-
TRAPPC6) have been crystallized (Sacher et al., 2008). Revealing the three-
dimensional structure of TRAMM will provide insights into its function and would allow us 
to address many unanswered questions. Despite the sequence homology, 





functions that would give us more insights into TRAMM's mitotic function. Besides 
crystallography, the recombinant protein could be incubated with lysates from cells 
arrested either in interphase (to identify membrane trafficking interactors) or in mitosis 
(to identify cell division interactors of which we expect CENP-E). Once interactors are 
identified, truncated forms of TRAMM would be used to map the regions on TRAMM 
where these proteins interact.  
 
Interestingly, ongoing research on several patients carrying mutations in TRAMM where 
the protein is undetectable results in a delay in mitosis (Milev et al, 2017). These 
patients have severe developmental delays, which could be correlated to the mitotic 
delay caused by the mutation in TRAMM. TRAMM is among many other proteins such 
as CHAMP1 (a zinc finger protein) that can cause defects in mitosis resulting in such 
diseases (Tanaka et al., 2016). It is noteworthy that one of the mutations identified in a 
patient with TRAMM mutations affects a highly conserved alanine that is a part of 
the TPR conserved motif (Zeytuni et al., 2012). 
 
TRAMM is amongvarious TRAPP subunits that are involved in a wide range of cellular 
activities. For example, the TRAPP II complex has been implicated in Rabin8 
centrosome targeting and cilia formation where C3, C9, and C10 are essential subunits 
for this process (Westlake et al., 2011).  
 
Apart from its functions in the TRAPP complex, including membrane trafficking and cilia 
formation, TRAPPC9 is speculated to be a moonlighting protein that functions in the NF-
kB pathway and neuronal differentiation in the cerebellum (Khattak et al., 2014). This is 
shown by TRAPPC9 interacting with NIK in a yeast two-hybrid screening, which is 
involved in the transcription of NF-kB. Mutations in TRAPPC9 have been identified in 
individuals that have microcephaly and non-syndromic autosomal-recessive mental 
retardation (Brunet and Sacher, 2014).  
 
The TRAPPC4 protein was suggested to regulate ERK signaling, but it is still unclear 
whether this is done in a TRAPP context or not (Brunet and Sacher, 2014). In a yeast 
two hybrid screening, TRAPPC4 interacts with ERK2 and directly affects the levels 
of phospho-ERK1/2 due to the possible involvement in its transportation from the 





function as increased levels of TRAPPC4 and phosphor-ERK1/2 are present in the 
nucleus of colonic carcinoma tissues, which may be independent of the TRAPP 
complex (Zhao et al., 2011).   
 
Other moonlighting functions involving the TRAPP complex are collagen secretion and 
glycosylation, which are specifically affected by TRAPPC2 and TRAPPC11 respectively 
(Jones et al., 2003; Venditti et al., 2012; DeRossi et al., 2016). TRAPPC2 mutations can 
be linked to skeletal specific X-linked Spondyloepiphyseal Dysplasia Tarda (SEDT) due 
to it altering collagen secretion and affecting Golgi integrity. The recruitment of TANGO1 
(a collagen receptor) by TRAPPC2 leads to its interaction with Sar1 (GTP-bound COPII) 
that is critical to the dissociation of Sar1 from the membrane at ER exit sites (Venditti et 
al., 2012). Mutations in Sar1B have shown to cause defects in the dissociation of 
chylomicrons from the ER which may lead to various types of chylomicron retention 
diseases (CMRD) (Jones et al., 2003). Further research into the interactions of 
TRAPPC2 with this pathway may assist in better understanding chylomicron dissociation 
and unanswered questions around CMRD (Brunet and Sacher, 2014). Other subunits in 
the complex such as TRAPPC2L and TRAPPC11 have also shown to have affect Golgi 
fragmentation, and may cause disorders ranging from neurodevelopmental delay of 
newborn children to miscarriages and lethality (Wen et al., 2015; Sacher et al., 2014).  
 
TRAPPC11 (a component of human TRAPP III) has shown to have critical effects on the 
Golgi and can be lethal to humans due to its high importance in development (Brunet 
and Sacher, 2014). One study has shown that the depletion of TRAPPC11 causes a 
stressed unfolded protein response (UPR), specifically ER stress-inducing UPR, which 
results in hypoglycosylation and accumulation of lipid droplets in fibroblasts (DeRossi et 
al, 2016). Viral insertion causing TRAPPC11 depletion in zebrafish was shown to reduce 
N-linked glycosylation which led to liver steatosis(DeRossi et al., 2016). In addition to the 
liver, TRAPPC11 plays a physiological role in multiple other tissues including the 
muscle, eye, brain, and bone (Liang et al., 2015). Although the detailed mechanisms 
causing the neurological and muscular defects in TRAPPC11 patients are still unknown, 
the vast majority of individuals with TRAPPC11 mutations suffer from intellectual 
disabilities and neuromuscular defects (such as type 2S limbe-girdle muscular 
dystrophy) caused by hypoglycosylation (Bögershausen et al., 2013). Collectively, the 





be due to the impairment of TRAPPC11 functions in multiple processes. 
 
Continual research on TRAPP and its subunits has shown its wide variety of 
moonlighting functions, which is found to play important roles in many cellular 
processes. This project has allowed us to take a step further to understand TRAMM and 
its newly reported function in mitosis. Yet many questions still need to be addressed, 
including: Is TRAMM a part of a multi-subunit complex during mitosis or does it only 
associate transiently with some protein partners such as CENP-E? Which phosphatase 
is responsible for dephosphorylating TRAMM? How does TRAMM associate back with 
the TRAPP complex during interphase? Not only the research in TRAMM and its 
correlation to the cell cycle needs further investigation, but research into the mammalian 
TRAPP complex as a whole is still in its infancy. The more we learn about the 
mammalian TRAPP complex, the greater we emphasize the importance of its research 
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